Some action points for the next PM
Express Pharma
MAY 7, 2024
Drug prices crash post-patent loss, due to this competition, which is good for patients but leaves drug makers struggling with thin profit margins. India’s traditional strength lies in small molecule chemical-based drugs which is why not too many companies focus on biologics.
105 
Let's personalize your content